series-c-plus
Stage
2007
Founded
2
Investors
About
ArcDia develops and manufactures automated multianalyte rapid antigen test systems for diagnosing acute infections, enabling simultaneous detection of multiple pathogens from a single clinical sample at point-of-care settings.
Explore ArcDia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.